These results may guide the development of future therapies for Alzheimer's disease and tauopathies to halt pathological tau while preserving healthy tau, thereby not further impairing motor and cognitive function in individuals suffering from these insidious diseases. This evidence concerns the gene MAPT and Alzheimer disease.